Dr. Patrick W. Serruys
"A Philosopher" of Cardiology
Dr. Patrick W. Serruys (Ireland) served as the Chief of Interventional Cardiology at the Thoraxcenter, Erasmus University, Rotterdam, and currently holds the position of Professor of Interventional Medicine and Innovation at the National University of Galway, Ireland. His groundbreaking contributions to interventional cardiology include advancements in bare-metal stents (BMS), drug-eluting stents (DES), bioresorbable scaffolds (BRS), and transcatheter aortic valve replacement (TAVR). He has also significantly advanced imaging techniques such as Quantitative Coronary Angiography (QCA), IVUS, and OCT. He has served as the principal investigator or co-PI in over 80 multinational clinical trials, including pivotal studies like the SYNTAX and EXCEL trials. With over 3,500 peer-reviewed publications and 42 books to his name, he is one of the most prolific contributors to cardiovascular medicine. His exceptional contributions have earned him numerous prestigious awards, including the TCT Career Achievement Award (1996), the Andreas Grüntzig Award (2000), the James B. Herrick Award (2006), the ACC Lifetime Achievement Award (2011), and the "Master of the Masters" Award at TCTAP (2019).
I'm personally very grateful that I have been able to join your team since 2007. I have learned so many things not only about interventional cardiology, but about so many other stuffs like basics in human communications, basics in scientific communications and how to put the people on the same page. (Yoshinobu Onuma) He has been a master of accumulating defining very large data sets. Data sets are related to Imaging such as early days of quantitative coronary angiography, data sets related to intravascular ultrasound, data sets related to OCT, those were clinical data sets. There were other data sets that he was able to master and then mastering that identified approaches to educate us and take us forward as we thought further about the field of interventional cardiology. (David R. Holmes)
The name Patrick W. Serruys is really synonymous with interventional cardiology. I can’t think of a single scientist who more comprehensively integrates an understanding of basic science and intravascular imaging and pathophysiology to clinical outcomes. (Gregg W. Stone) The development of interventional cardiology would be totally incomplete without Patrick W. Serruys. The trials you’ve done, the drive you’ve had and the things that you have driven to help us understand better this specialty are unparalleled. This honor could go to no one more deserving than Patrick W. Serruys. And even though we have competed in some areas, journals and other things, I think you are the most deserving winner I can imagine for this award. Congratulations Patrick! (Spencer B. King III) Patrick is the dean, he is the pope of the academic interventional cardiology for the past four decades. What he has done to be able to elevate the field from the standpoint of academic recognition and clinical evidence has literally put interventional cardiology on the map. (Martin Bert Leon)
It was April 28, 2011, Dr. Serruys's birthday. After his lecture, Dr. Eun-Seok Shin, one of his former fellows, surprised him with a birthday cake, and he was visibly delighted. One small memory that lingers in my mind is when we published our AMC data, which showed that the SYNTAX Score had limited ability to predict long-term clinical outcomes, especially in left main disease. After that, I found it difficult to make eye contact with him at conferences for a while.
Dr. Patrick W. Serruys (Ireland) served as the Chief of Interventional Cardiology at the Thoraxcenter, Erasmus University, Rotterdam, and currently holds the position of Professor of Interventional Medicine and Innovation at the National University of Galway, Ireland. His groundbreaking contributions to interventional cardiology include advancements in bare-metal stents (BMS), drug-eluting stents (DES), bioresorbable scaffolds (BRS), and transcatheter aortic valve replacement (TAVR). He has also significantly advanced imaging techniques such as Quantitative Coronary Angiography (QCA), IVUS, and OCT. He has served as the principal investigator or co-PI in over 80 multinational clinical trials, including pivotal studies like the SYNTAX and EXCEL trials. With over 3,500 peer-reviewed publications and 42 books to his name, he is one of the most prolific contributors to cardiovascular medicine. His exceptional contributions have earned him numerous prestigious awards, including the TCT Career Achievement Award (1996), the Andreas Grüntzig Award (2000), the James B. Herrick Award (2006), the ACC Lifetime Achievement Award (2011), and the "Master of the Masters" Award at TCTAP (2019).
I'm personally very grateful that I have been able to join your team since 2007. I have learned so many things not only about interventional cardiology, but about so many other stuffs like basics in human communications, basics in scientific communications and how to put the people on the same page. (Yoshinobu Onuma) He has been a master of accumulating defining very large data sets. Data sets are related to Imaging such as early days of quantitative coronary angiography, data sets related to intravascular ultrasound, data sets related to OCT, those were clinical data sets. There were other data sets that he was able to master and then mastering that identified approaches to educate us and take us forward as we thought further about the field of interventional cardiology. (David R. Holmes)
The name Patrick W. Serruys is really synonymous with interventional cardiology. I can’t think of a single scientist who more comprehensively integrates an understanding of basic science and intravascular imaging and pathophysiology to clinical outcomes. (Gregg W. Stone) The development of interventional cardiology would be totally incomplete without Patrick W. Serruys. The trials you’ve done, the drive you’ve had and the things that you have driven to help us understand better this specialty are unparalleled. This honor could go to no one more deserving than Patrick W. Serruys. And even though we have competed in some areas, journals and other things, I think you are the most deserving winner I can imagine for this award. Congratulations Patrick! (Spencer B. King III) Patrick is the dean, he is the pope of the academic interventional cardiology for the past four decades. What he has done to be able to elevate the field from the standpoint of academic recognition and clinical evidence has literally put interventional cardiology on the map. (Martin Bert Leon)
It was April 28, 2011, Dr. Serruys's birthday. After his lecture, Dr. Eun-Seok Shin, one of his former fellows, surprised him with a birthday cake, and he was visibly delighted. One small memory that lingers in my mind is when we published our AMC data, which showed that the SYNTAX Score had limited ability to predict long-term clinical outcomes, especially in left main disease. After that, I found it difficult to make eye contact with him at conferences for a while.